Augmedix Inc. (NASDAQ:AUGX) will be acquired by Commure, Inc., in an all-cash transaction valued at approximately $139 million in equity.
Under the agreement, Augmedix stockholders will receive $2.35 per share in cash upon completion of the proposed transaction, and Augmedix will become a wholly-owned subsidiary of Commure.
Augmedix delivers AI medical documentation products to healthcare systems, physician practices, hospitals, and telemedicine practitioners.
Commure offers a suite of automated and AI-enabled hardware, software, and services for the healthcare sector.
The purchase price represents a premium of approximately 169% over the volume-weighted average price (VWAP) of Augmedix’s common stock for ...